<SEC-DOCUMENT>0001193125-17-089329-index.html : 20170320
<SEC-HEADER>0001193125-17-089329.hdr.sgml : 20170320
<ACCEPTANCE-DATETIME>20170320161003
ACCESSION NUMBER:		0001193125-17-089329
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170320
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170320
DATE AS OF CHANGE:		20170320

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		17701509

	BUSINESS ADDRESS:	
		STREET 1:		10182 TELESIS COURT, 6TH FLOOR
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		10182 TELESIS COURT, 6TH FLOOR
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d362479d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: d362479d8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>d362479dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 2 - file: d362479dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d362479dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 3 - file: d362479dex991.htm

</DOCUMENT>
</SEC-DOCUMENT>